These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 20586780)

  • 1. Matrix metalloproteinase-7 activates heparin-binding epidermal growth factor-like growth factor in cutaneous squamous cell carcinoma.
    Kivisaari AK; Kallajoki M; Ala-aho R; McGrath JA; Bauer JW; Königová R; Medvecz M; Beckert W; Grénman R; Kähäri VM
    Br J Dermatol; 2010 Oct; 163(4):726-35. PubMed ID: 20586780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane type 1-matrix metalloproteinase cleaves off the NH2-terminal portion of heparin-binding epidermal growth factor and converts it into a heparin-independent growth factor.
    Koshikawa N; Mizushima H; Minegishi T; Iwamoto R; Mekada E; Seiki M
    Cancer Res; 2010 Jul; 70(14):6093-103. PubMed ID: 20587521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated extracellular signal-regulated kinases: association with epidermal growth factor receptor/transforming growth factor alpha expression in head and neck squamous carcinoma and inhibition by anti-epidermal growth factor receptor treatments.
    Albanell J; Codony-Servat J; Rojo F; Del Campo JM; Sauleda S; Anido J; Raspall G; Giralt J; Roselló J; Nicholson RI; Mendelsohn J; Baselga J
    Cancer Res; 2001 Sep; 61(17):6500-10. PubMed ID: 11522647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of cell surface CD44 in nonmelanoma skin tumours is associated with increased expression of matrix metalloproteinase 7.
    Hartmann-Petersen S; Tammi RH; Tammi MI; Kosma VM
    Br J Dermatol; 2009 Jun; 160(6):1251-7. PubMed ID: 19222463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine stimulation of MMP-1(collagenase-1) secretion and gene expression in gastric epithelial cells: role of EGFR transactivation and the MAP kinase pathway.
    Ancha HR; Kurella RR; Stewart CA; Damera G; Ceresa BP; Harty RF
    Int J Biochem Cell Biol; 2007; 39(11):2143-52. PubMed ID: 17656145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transactivation of epidermal growth factor receptor after heparin-binding epidermal growth factor-like growth factor shedding in the migration of prostate cancer cells promoted by bombesin.
    Madarame J; Higashiyama S; Kiyota H; Madachi A; Toki F; Shimomura T; Tani N; Oishi Y; Matsuura N
    Prostate; 2003 Nov; 57(3):187-95. PubMed ID: 14518027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmin-induced smooth muscle cell proliferation requires epidermal growth factor activation through an extracellular pathway.
    Roztocil E; Nicholl SM; Galaria II; Davies MG
    Surgery; 2005 Aug; 138(2):180-6. PubMed ID: 16153425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells.
    O-charoenrat P; Modjtahedi H; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Cancer Res; 2000 Feb; 60(4):1121-8. PubMed ID: 10706134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells.
    Wang F; Sloss C; Zhang X; Lee SW; Cusack JC
    Cancer Res; 2007 Sep; 67(18):8486-93. PubMed ID: 17875687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-7-catalyzed release of HB-EGF mediates deoxycholyltaurine-induced proliferation of a human colon cancer cell line.
    Cheng K; Xie G; Raufman JP
    Biochem Pharmacol; 2007 Apr; 73(7):1001-12. PubMed ID: 17222808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic activation of heparin-binding EGF-like growth factor by membrane-type matrix metalloproteinase-1 in ovarian carcinoma cells.
    Koshikawa N; Mizushima H; Minegishi T; Eguchi F; Yotsumoto F; Nabeshima K; Miyamoto S; Mekada E; Seiki M
    Cancer Sci; 2011 Jan; 102(1):111-6. PubMed ID: 20946474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
    Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
    J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the epidermal growth factor signalling pathway by tissue plasminogen activator in pancreas cancer cells.
    Hurtado M; Lozano JJ; Castellanos E; López-Fernández LA; Harshman K; Martínez-A C; Ortiz AR; Thomson TM; Paciucci R
    Gut; 2007 Sep; 56(9):1266-74. PubMed ID: 17452424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
    Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
    Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
    Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
    Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.
    Di Simone N; Marana R; Castellani R; Di Nicuolo F; D'Alessio MC; Raschi E; Borghi MO; Chen PP; Sanguinetti M; Caruso A; Meroni PL
    Arthritis Rheum; 2010 May; 62(5):1504-12. PubMed ID: 20131286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM; Saigal B; Donato NJ
    J Cell Physiol; 2005 Nov; 205(2):218-27. PubMed ID: 15887238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
    Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.